Recall archive / FDA drug enforcement
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar. — FDA record D-1104-2023
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Aug 14, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
- Reason
- CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
- Classification
- Class II
- Recalling firm
- Inmar Supply Chain Solutions, LLC
- Quantity
- Unknown
- Agency-reported status
- Ongoing
- Source record identifier
- D-1104-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Miscellaneous |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Report date
- Aug 30, 2023
- Recall initiation date
- Aug 14, 2023
- Center classification date
- Aug 24, 2023
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.